Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database Journal Article
| Authors: | Roman, B. R.; Baxi, S. S.; Cracchiolo, J. R.; Blackwell, T. J.; Pfister, D. G.; McBride, S.; Ganly, I.; Shah, J. P.; Patel, S. G.; Morris, L. G.; Cohen, M. A. |
| Article Title: | Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database |
| Abstract: | Background and Objectives: Primary surgical treatment of patients with early T-classification (T1-T2) oropharyngeal squamous cell carcinoma (OPSCC) has increased. We sought to determine how often these patients receive postoperative chemoradiation (CRT). Methods: Patients with T1-T2 OPSCC in the National Cancer Database who underwent primary surgery were evaluated for receipt of postoperative CRT. Postoperative CRT use was examined among patients with high risk factors (positive margins and/or extracapsular spread [ECS]), intermediate risk factors (negative margins, no ECS, and either pT3-4 and/or N2-N3), and no apparent risk factors. Results: Of 4833 patients with T1-T2 OPSCC who underwent primary surgery, 43% had high risk pathologic factors, of whom only 63% received postoperative CRT. Another 31% had no apparent risk factors, of whom 16% nonetheless received postoperative CRT. On multivariable analysis, in addition to tumor and demographic factors, patients treated at community hospitals were more likely to receive postoperative CRT (O.R. 1.41 C.I. 1.18-1.87, P = 0.001). Conclusions: Variation in postoperative CRT use indicates a lack of consensus and/or knowledge about its benefits and indications. Usage of postoperative CRT regardless of pathologic risk factors suggests an area where future efforts at implementation of best practices may be targeted. © 2017 Wiley Periodicals, Inc. |
| Keywords: | adjuvant chemoradiation (postoperative crt); hospital-level variation; hpv-related oropharyngeal squamous cell carcinoma (opscc); national comprehensive cancer network (nccn) guidelines; pathologic risk factors |
| Journal Title: | Journal of Surgical Oncology |
| Volume: | 116 |
| Issue: | 3 |
| ISSN: | 0022-4790 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-09-01 |
| Start Page: | 351 |
| End Page: | 358 |
| Language: | English |
| DOI: | 10.1002/jso.24674 |
| PROVIDER: | scopus |
| PMCID: | PMC5533641 |
| PUBMED: | 28570758 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 14 August 2017 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work